Skip to main content

Table 1 Preoperative demographics

From: Transapical aortic valve implantation in patients with pre-existing mitral valve prostheses: a case report

  Patient 1 Patient 2
Age [y] 76 74
Sex Male Male
EOA [cm2] 0.4 0.7
EOAI [cm2/m2] 0.21 0.32
Pre-op ΔPmean [mmHg] 83 35
LVEF [%] 61 65
NYHA-class III III
NTproBNP [pg/ml] 1086 2461
CCS I II
CABG No Yes
MVR Mechanical Valve (Carbomedics, 27 mm) Biological Valve (Perimount Plus, 27 mm)
Chronic atrial fibrillation Yes Yes
COPD [GOLD] IV III
PHT Moderate Severe
PAD [Fontaine] II II
EuroSCORE I [%] 32.83 55.56
EuroSCORE II [%] 11.61 11.08
STS-score, PROM [%] 5.52 6.72
  1. (CABG coronary artery bypass grafting, CCS Canadian Cardiovascular Society, COPD chronic obstructive pulmonary disease, EOA effective orifice area, EOAI effective orifice area index, EuroSCORE European System for Cardiac Operative Risk Evaluation, LVEF left ventricular ejection fraction, MVR Mitral valve replacement, NYHA New York Heart Association, PAD peripheral arterial disease-fontaine classification, PHT pulmonary hypertension, Pre-Op Δp mean preoperative mean transaortic pressure gradient, STS-score, PROM Society of Thoracic Surgeons-score, predictive risk of mortality, y years)